Showing results 43 to 62 of 69
< previous
next >
Issue Date | Title | Type | Author(s) |
2003 | Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response | Articulo | Aguirre-Ena, X. (Xabier); Fontalba, A. (A.); Andreu, E.J. (Enrique José); Odero, M.D. (Maria Dolores); Larrayoz, M.J. (María J.); Montiel-Duarte, C. (Cristina); Calasanz-Abinzano, M.J. (Maria Jose); Fernandez-Luna, J.L. (J.L.); Prosper-Cardoso, F. (Felipe) |
1991 | Luciano PEREÑA (ed.), La protección del indio, Universidad Pontificia de Salamanca, Salamanca 1989, 263 pp., 14 x 21. [RECENSIÓN] | Reseña | Odero, M.D. (Maria Dolores) |
1992 | Medard KEHL, «Nueva Era» frente al cristianismo, Herder, Barcelona 1990, 154 pp., 12 x 20. [RECENSIÓN] | Reseña | Odero, M.D. (Maria Dolores) |
2004 | Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells | Articulo | Lahortiga, I. (Idoya); Aguirre-Ena, X. (Xabier); Belloni, E. (E.); Vazquez, I. (Iria); Larrayoz, M.J. (María J.); Gasparini, P. (P.); Lo-Coco, F. (Francesco); Pelicci, P.G. (Pier G.); Calasanz-Abinzano, M.J. (Maria Jose); Odero, M.D. (Maria Dolores) |
2003 | Molecular cytogenetic characterization of breakpoints in 19 patients with hematologic malignancies and 12p unbalanced translocations | Articulo | Odero, M.D. (Maria Dolores); Carlson, K. (K.); Lahortiga, I. (Idoya); Calasanz-Abinzano, M.J. (Maria Jose); Rowley, J.D. (Janet D.) |
2004 | Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements | Articulo | Lahortiga, I. (Idoya); Vazquez, I. (Iria); Aguirre-Ena, X. (Xabier); Larrayoz, M.J. (María J.); Vizmanos-Pérez, J.L. (José Luis); Gozzetti, A. (A.); Calasanz-Abinzano, M.J. (Maria Jose); Odero, M.D. (Maria Dolores) |
2007 | Multicolor interphase cytogenetics for the study of plasma cell dyscrasias | Articulo | Saez, B. (Borja); Martin-Subero, J.I. (Jose Ignacio); Odero, M.D. (Maria Dolores); Prosper-Cardoso, F. (Felipe); Cigudosa, J.C. (Juan Cruz); Schoch, R. (Robert); Calasanz-Abinzano, M.J. (Maria Jose); Siebert, R. (Reiner) |
2012 | Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics | Articulo | Boultwood, J. (Jacqueline); Wainscoat, J.S. (James S.); Calasanz-Abinzano, M.J. (Maria Jose); Prosper-Cardoso, F. (Felipe); Aguirre-Ena, X. (Xabier); Odero, M.D. (Maria Dolores); McDonald, E.J. (Emma Jane); Killick, S. (Sally); Perez, C. (Cristina); Kondo, T. (Toshinori); Larrayoz, M.J. (María J.); Davies, C. (Carwyn); Pellagatti, A. (Andrea); Yip, B.H. (Bon Ham); Fernandez-Mercado, M. (Marta) |
2001 | New cytogenetic prognostic markers in breast cancer | Articulo | Zudaire, I. (Isabel); Odero, M.D. (Maria Dolores); Caballero, M.C. (M.C.); Valenti, C. (C.); Martinez-Peñuela, J.M. (J.M.); Calasanz-Abinzano, M.J. (Maria Jose) |
2004 | NIN, a gene encoding a CEP110-like centrosomal protein, is fused to PDGFRB in a patient with a t(5;14)(q33;q24) and an imatinib-responsive myeloproliferative disorder | Articulo | Vizmanos-Pérez, J.L. (José Luis); Novo-Villaverde, F. J. (Francisco Javier); Roman, J.P. (José P.); Baxter, E.J. (E.J.); Lahortiga, I. (Idoya); Larrayoz, M.J. (María J.); Odero, M.D. (Maria Dolores); Giraldo, P. (P.); Calasanz-Abinzano, M.J. (Maria Jose); Cross, N.C.P. (Nicholas C.P.) |
2003 | NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15) | Articulo | Lahortiga, I. (Idoya); Vizmanos-Pérez, J.L. (José Luis); Aguirre-Ena, X. (Xabier); Vazquez, I. (Iria); Cigudosa, J.C. (Juan Cruz); Larrayoz, M.J. (María J.); Sala, F. (Francisco); Gorosquieta, A. (A.); Perez-Equiza, K. (Katy); Calasanz-Abinzano, M.J. (Maria Jose); Odero, M.D. (Maria Dolores) |
2005 | NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2 | Articulo | Lahortiga, I. (Idoya); Belloni, E. (E.); Vazquez, I. (Iria); Aguirre-Ena, X. (Xabier); Larrayoz, M.J. (María J.); Vizmanos-Pérez, J.L. (José Luis); Valgañon, M. (Mikel); Zudaire, I. (Isabel); Saez, B. (Borja); Mateos, M.C. (María C.); Di-Fiore, P.P. (Pier Paolo); Calasanz-Abinzano, M.J. (Maria Jose); Odero, M.D. (Maria Dolores) |
2012 | Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia | Articulo | Cristobal, I. (Ion); Garcia-Orti, L. (Laura); Cirauqui, C. (Cristina); Cortes-Lavaud, X. (Xabier); Garcia-Sanchez, M.A. (María A.); Calasanz-Abinzano, M.J. (Maria Jose); Odero, M.D. (Maria Dolores) |
2005 | p53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IV | Articulo | Valgañon, M. (Mikel); Giraldo, P. (P.); Aguirre-Ena, X. (Xabier); Larrayoz, M.J. (María J.); Rubio-Martinez, A. (Araceli); Rubio-Felix, D. (Daniel); Calasanz-Abinzano, M.J. (Maria Jose); Odero, M.D. (Maria Dolores) |
8-Jan-2013 | Papel de la proteína fosfatasa 2A (PP2A) y su inhibidor endógeno SET en la leucemia mieloide aguda | Tesis | Cristobal, I. (Ion) |
1991 | Peter HARRISON, «Religion» and the religions in the English Enlightenment, Cambridge 1990, IX + 227 pp., 15,5 x 23,5. [RECENSIÓN] | Reseña | Odero, M.D. (Maria Dolores) |
2023 | Regulation and role of the PP2A-B56 holoenzyme family in cancer | Articulo | Peris-Martínez, I. (Irene); Romero-Murillo, S. (Silvia); Vicente, C. (Carmen); Narla, G. (Goutham); Odero, M.D. (Maria Dolores) |
2004 | Remission of acute monocytic leukemia, secondary to treatment with epipodophyllotoxins, in a patient with t(8;16)(p11;p13) and MYST3-CREBBP fusion | Articulo | Vizmanos-Pérez, J.L. (José Luis); Larrayoz, M.J. (María J.); Vazquez, I. (Iria); Odero, M.D. (Maria Dolores); Hernandez, R. (Roberto); Lahortiga, I. (Idoya); Novo-Villaverde, F. J. (Francisco Javier); Ardanaz, M.T. (M.T.); Calasanz-Abinzano, M.J. (Maria Jose) |
1993 | Rodney Stenning EDGECOMBE, Vocation and identity in the Fiction of Muriel Spark, University of Missouri Press, Columbia and London 1990, 165 pp., 14 x 21. [RECENSIÓN] | Reseña | Odero, M.D. (Maria Dolores) |
2018 | Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib | Articulo | Macias, R. (Rocío); Sánchez-Martín, A. (Anabel); Rodríguez-Macías, G. (Gabriela); Sanchez-Abarca, L.I. (Luis Ignacio); Lozano, E. (Elisa); Herraez, E. (Elisa); Odero, M.D. (Maria Dolores); Díez-Martín, J.L. (José L.); Marin, J.J.G (Jose J.G.); Briz, O. (Oscar) |